Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on March 22nd, 2011% Researchers at Queen’s University in Belfast, U.K. have completed the first analysis of all food recalls announced in the U.S., U.K., and Ireland over the last decade. The findings will be presented at the Food Integrity and Traceability Conference taking place at Queen’s University this week.
The research by Antony Potter at the university’s Centre . . . → Read More: Study: Food Scares and Product Recalls Increasing
By Alan, on March 22nd, 2011% (NOAA.gov)
Researchers at the Virginia Institute of Marine Science (VIMS) in Gloucester Point joined with local oyster growers to sharply reduce a bacterium harmful to humans found in farmed oysters. Their findings may offer a lower-cost solution to new Food and Drug Administration (FDA) regulations that many growers believe can affect the oyster . . . → Read More: Public-Private Research Helps Oyster Growers Meet FDA Regs
By Alan, on March 21st, 2011% 3D lens (Kevin Fitzsimons, Ohio State University)
Engineers at Ohio State University in Columbus have invented a lens that enables microscopic objects to be seen from nine different angles at once to create a 3D image. Engineering professor Allen Yi, and postdoctoral researcher Lei Li discuss the lens in the November 2010 issue . . . → Read More: University Engineers Develop Single Lens for 3D Microscope
By Alan, on March 21st, 2011% (National Renewable Energy Laboratory)
A graduate student at Kansas State University in Manhattan is conducting research that shows how distributed energy sources like wind power can help reduce widespread power outages. Engineering doctoral student Sakshi Pahwa presented her findings earlier this year at the Capitol Graduate Research Summit in Topeka, Kansas.
The research . . . → Read More: Kansas Winds Could Help Avoid Widespread Power Outages
By Alan, on March 21st, 2011% Gang Zheng (University Health Network)
A research team at Ontario Cancer Institute in Toronto, Canada have created an organic nanoparticle that they say can potentially change the way tumors are treated. Their findings appear online in the journal Nature Materials (paid subscription required).
The researchers, led by the institute’s Gang Zheng (pictured left), . . . → Read More: Organic Nanoparticle in Development for Cancer Drug Delivery
By Alan, on March 21st, 2011% Medicago Inc., a biotechnology company in Quebec City, Canada has begun a phase I clinical trial of its H1N1 influenza vaccine candidate in the United States. The trial tests the drug’s safety, tolerability, and capacity to induce an immune response, with results expected in three months.
The randomized, double-blind, multicenter, active- and placebo-controlled dose-ranging study . . . → Read More: Clinical Trial Underway for Seasonal/H1N1 Vaccine
By Alan, on March 18th, 2011% (Photos8.com)
Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter.
Biomedical/Life Sciences
Advanced Animal Diagnostics in Durham, North Carolina raised $11 million in equity funding with Intersouth Partners and Novartis Venture Funds, the venture capital arm of Novartis Pharmaceuticals, and others.
. . . → Read More: Finance Friday: 18 March 2011
By Alan, on March 18th, 2011% (Brookhaven National Lab)
Engineers at University of Pittsburgh in Pennsylvania have begun research on upgrades needed in the U.S. electrical grid to better integrate direct current (DC) power in an infrastructure designed for alternating current (AC). Funding for the project includes a recent $600,000 support grant from the Commonwealth of Pennsylvania’s Ben Franklin . . . → Read More: Engineers Research Grid Upgrades to Handle More DC Power
By Alan, on March 18th, 2011% (Yale School of Medicine/Wikimedia Commons)
Researchers from University of Miami in Florida and BioCardia, a cardiac device manufacturer in San Carlos, California have shown that stem cells injected into enlarged hearts can reduce heart size, reduce scar tissue, and improve function to injured heart areas. The results of this small trial appear in . . . → Read More: Early Trial Indicates Stem Cells Can Reverse Heart Damage
By Alan, on March 18th, 2011% Artist's drawing of proposed bioenergy lab (Aston Univ.)
Aston University in Birmingham, U.K. plans to build new £16.5 million ($26.7 million) engineering laboratories to develop and demonstrate renewable low carbon technologies including a biomass fueled power plant. The facility (artist’s drawing pictured right) is scheduled to open on the Aston campus in October . . . → Read More: Univ. Bioenergy Lab to Develop Low Carbon Technologies
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.